Efficacy and Safety of MLC601 in Patients with Mild to Moderate Alzheimer Disease: An Extension 4-Year Follow-Up Study
Conclusion: The efficacy of treating AD patients with MLC601 over 4 years has been demonstrated in the present study. Overall, it seems that the safety and efficacy of MLC601 is promising compared to currently prescribed treatments.Dement Geriatr Cogn Disord Extra 2018;8:174 –179
Source: Dementia and Geriatric Cognitive Disorders Extra - Category: Geriatrics Source Type: research
More News: Alzheimer's | Dementia | Gastroenterology | Geriatrics | Laboratory Medicine | Men | Statistics | Study